Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

DREAMM-7 - Belantamab-Mafodotin 2,5 / Bortezomib 1,3 / Dexamethason 20, multiples Myelom, Zyklus 1-8

Protocol-ID: 3174 V1.0 (Mini), DREAMM-7 - BELMAF2,5/BORT1,3/DEXA20, MM, Z1-8

Indication(s)

  • Multiple Myeloma; ICD-10 C90.-, C90.0-
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician.

Valid since: 26.03.2026